Apellis Pharmaceuticals Ownership | Who Owns Apellis Pharmaceuticals?
Apellis Pharmaceuticals Ownership Summary
Apellis Pharmaceuticals is owned by 10.07% institutional investors, 13.73% insiders, and 76.20% retail investors. Avoro capital advisors is the largest institutional shareholder, holding 9.74% of APLS shares. Vanguard Health Care Inv is the top mutual fund, with 4.94% of its assets in Apellis Pharmaceuticals shares.
APLS Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Apellis Pharmaceuticals | 10.07% | 13.73% | 76.20% |
| Sector | Healthcare Stocks | 279.42% | 10.64% | -190.05% |
| Industry | Biotech Stocks | 64.05% | 10.69% | 25.27% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Avoro capital advisors | 12.22M | 9.74% | $267.30M |
| Ecor1 capital | 11.89M | 9.60% | $379.44M |
| Wellington management group llp | 11.80M | 9.52% | $376.57M |
| Vanguard group | 10.05M | 8.11% | $320.57M |
| Blackrock funding, inc. /de | 6.48M | 5.23% | $206.71M |
| Blackrock | 5.80M | 4.71% | $222.31M |
| Deep track capital, lp | 5.00M | 3.99% | $109.35M |
| State street | 4.53M | 3.65% | $144.40M |
| Siren | 2.82M | 2.27% | $89.87M |
| Jennison associates | 2.76M | 2.23% | $88.08M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Ecor1 capital | 11.89M | 14.35% | $379.44M |
| Avoro capital advisors | 12.22M | 4.17% | $267.30M |
| Siren | 2.82M | 3.97% | $89.87M |
| Deep track capital, lp | 5.00M | 3.54% | $109.35M |
| Boxer capital | 1.73M | 3.49% | $66.21M |
| Ghost tree capital | 135.00K | 1.62% | $5.18M |
| Artal group | 1.47M | 1.43% | $56.28M |
| Highvista strategies | 108.71K | 1.29% | $3.47M |
| Braidwell lp | 1.65M | 1.27% | $36.14M |
| Sphera funds management | 206.25K | 1.19% | $6.58M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ubs group | 2.59M | 0.02% | 2.27M |
| Orbimed advisors | 1.43M | 0.75% | 1.43M |
| National bank of canada /fi/ | 1.39M | 0.05% | 1.39M |
| Royal bank of canada | 1.52M | 0.01% | 1.38M |
| Norges bank | 1.09M | 0.00% | 1.09M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Wellington management group llp | 11.80M | 0.07% | -3.77M |
| Jpmorgan chase | 411.55K | 0.00% | -3.47M |
| Octagon capital advisors lp | - | - | -3.01M |
| T. rowe price investment management | 47.71K | 0.00% | -2.94M |
| Fiera capital | - | - | -1.35M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Norges bank | 1.09M | 0.00% | 1.09M | $34.66M |
| Natixis | 870.63K | 0.17% | 870.63K | $27.78M |
| Suvretta capital management | 793.19K | 0.86% | 793.19K | $25.31M |
| Verition fund management | 50.41K | 0.01% | 50.41K | $1.61M |
| Raymond james financial | 49.02K | 0.00% | 49.02K | $1.56M |
Sold Out
| Holder | Change |
|---|---|
| Jfs wealth advisors | -1.00 |
| Activest wealth management | -1.00 |
| Concourse financial group securities | -1.00 |
| Creative financial designs inc /adv | -5.00 |
| Fortitude family office | -6.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 6 | -97.89% | 12,635,786 | -90.03% | 10 | 0.10% | 2 | -98.73% | 1 | -98.68% |
| Dec 31, 2024 | 99 | -66.10% | 25,361,392 | -78.34% | 20 | 0.23% | 57 | -59.57% | 27 | -71.28% |
| Sep 30, 2024 | 291 | 2.46% | 117,076,868 | 1.49% | 94 | 1.09% | 142 | -12.35% | 93 | 43.08% |
| Jun 30, 2024 | 284 | -13.41% | 115,360,815 | 2.98% | 93 | 1.12% | 162 | -2.41% | 65 | -32.29% |
| Mar 31, 2024 | 328 | -0.30% | 112,027,605 | -1.51% | 91 | 0.99% | 166 | 14.48% | 96 | -14.29% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Health Care Inv | 6.24M | 4.94% | -3.04M |
| Vanguard Total Stock Mkt Idx Inv | 3.43M | 2.72% | 17.62K |
| Vanguard US Total Market Shares ETF | 3.30M | 2.63% | 2.68K |
| Vanguard Small Cap Index | 2.61M | 2.07% | -55.45K |
| SPDR® S&P Biotech ETF | 1.75M | 1.38% | 43.06K |
| Vanguard Institutional Extnd Mkt Idx Tr | 1.67M | 1.32% | 5.90K |
| Vanguard Small Cap Growth Index Inv | 1.47M | 1.16% | -227.00 |
| JPM US Mid Cap Growth-Composite | 1.30M | 1.07% | 294.66K |
| Polar Capital Biotech S Inc | 1.35M | 1.07% | - |
| JPMorgan Mid Cap Growth I | 1.30M | 1.05% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jul 17, 2025 | Francois Cedric | Chief Executive Officer | Sell | $398.73K |
| Jul 16, 2025 | Watson David O. | General Counsel | Sell | $97.75K |
| Jul 15, 2025 | Francois Cedric | Chief Executive Officer | Sell | $38.17K |
| Jul 14, 2025 | Francois Cedric | Chief Executive Officer | Sell | $2.77M |
| Jun 16, 2025 | Watson David O. | General Counsel | Sell | $93.85K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | - | 4 |
| 2025 Q2 | - | 1 |
| 2025 Q1 | - | 43 |
| 2024 Q4 | - | 2 |
| 2024 Q3 | - | 4 |
APLS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools